Eve Burstein
Stock Analyst at Bernstein
(4.64)
# 858
Out of 5,023 analysts
130
Total ratings
78%
Success rate
27.5%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Reiterated: Buy | $180 | $167.78 | +7.28% | 16 | Sep 25, 2026 | |
| AVTR Avantor | Reiterated: Hold | $16 | $15.34 | +1.04% | 13 | Sep 25, 2026 | |
| BIIB Biogen | Reiterated: Buy | $236 | $219.88 | +7.33% | 1 | Sep 25, 2026 | |
| GH Guardant Health | Reiterated: Buy | $210 | $177.80 | +18.11% | 12 | Sep 25, 2026 | |
| ILMN Illumina | Reiterated: Hold | $215 | $273.04 | -21.26% | 17 | Sep 25, 2026 | |
| IMVT Immunovant | Reiterated: Hold | $37 | $33.62 | +10.05% | 1 | Sep 25, 2026 | |
| NTRA Natera | Reiterated: Buy | $365 | $410.35 | -11.05% | 12 | Sep 25, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $756 | $735.20 | +2.83% | 1 | Sep 25, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | $41 | $35.72 | +14.78% | 1 | Sep 25, 2026 | |
| RVTY Revvity | Reiterated: Hold | $120 | $151.53 | -20.81% | 13 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $575 | $654.80 | -12.19% | 17 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 | $425.21 | +5.83% | 15 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 → $1.7 | $2.54 | n/a | 10 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €194.00 | €251.40 | n/a | 1 | Jan 6, 2025 |
Agilent Technologies
Sep 25, 2026
Reiterated: Buy
Price Target: $180
Current: $167.78
Upside: +7.28%
Avantor
Sep 25, 2026
Reiterated: Hold
Price Target: $16
Current: $15.34
Upside: +1.04%
Biogen
Sep 25, 2026
Reiterated: Buy
Price Target: $236
Current: $219.88
Upside: +7.33%
Guardant Health
Sep 25, 2026
Reiterated: Buy
Price Target: $210
Current: $177.80
Upside: +18.11%
Illumina
Sep 25, 2026
Reiterated: Hold
Price Target: $215
Current: $273.04
Upside: -21.26%
Immunovant
Sep 25, 2026
Reiterated: Hold
Price Target: $37
Current: $33.62
Upside: +10.05%
Natera
Sep 25, 2026
Reiterated: Buy
Price Target: $365
Current: $410.35
Upside: -11.05%
Regeneron Pharmaceuticals
Sep 25, 2026
Reiterated: Hold
Price Target: $756
Current: $735.20
Upside: +2.83%
Roivant Sciences
Sep 25, 2026
Reiterated: Buy
Price Target: $41
Current: $35.72
Upside: +14.78%
Revvity
Sep 25, 2026
Reiterated: Hold
Price Target: $120
Current: $151.53
Upside: -20.81%
Sep 25, 2026
Reiterated: Hold
Price Target: $575
Current: $654.80
Upside: -12.19%
Sep 25, 2026
Reiterated: Buy
Price Target: $450
Current: $425.21
Upside: +5.83%
Aug 8, 2025
Reiterated: Buy
Price Target: $1.5 → $1.7
Current: $2.54
Upside: n/a
Jan 6, 2025
Reiterated: Sell
Price Target: €194.00
Current: €251.40
Upside: n/a